Nutanix Inc NTNX shares were slipping Friday morning in reaction to the fiscal fourth-quarter results released after the close Thursday.
The Analyst
Morgan Stanley analyst Katy Huberty maintained an Equal-weight rating on Nutanix and increased the price target from $55 to $57.
The Thesis
Expense growth at Nutanix was directed toward better segmenting the salesforce; improving the core platform; multicloud software; and future services, Huberty said in the Friday note. (See the analyst's track record here.)
The business investments led to a sharp reduction in Morgan Stanley's EPS and FCF estimates for 2019, the analyst said.
Yet Huberty said investors may do well to focus on the company's top-line and billings growth momentum near-term, especially due to stronger-than-expected software and support billings growth, accelerating HCI market growth and positive customer and partner feedback on the Nutanix software roadmap.
The investments are self-funded with the company's FCF in 2018, while 2019 is likely to be FCF-neutral, the analyst said.
Although the company's guidance that calls for Q1 revenue of $295 million to $310 million and billings of $370 million to $390 million appears soft, Huberty said the shortfall relative to her estimate is due to the faster run-off of hardware revenue and her 12.5 times bill-to-revenue ratio estimate, which is below the guidance for 12.6 times.
Morgan Stanley projects that Nutanix can sustain 40-percent billings growth over the next two years.
" ... We think investors will ultimately reward the company for investing and modestly raise [the price target] to $57," Huberty said.
The Price Action
Nutanix shares have gained about 72 percent year-to-date.
The stock was slipping 6.8 percent off the open to $56.66 Friday.
Related Links:
JPMorgan Upgrades Nutanix Ahead Of Q4 Report, Sees Balanced Risk-Reward Profile
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.